2026-09-11
The 8th CMC-CHINA Pharmaceutical Industry Expo was held at the Suzhou International Expo Center from September 4 to 5, 2026. Suzhou Tianji Biopharma showcased its end-to-end peptide development and manufacturing capabilities, along with its core product portfolio, highlighting the company’s technical expertise and extensive experience in the peptide sector.
Throughout the event, our team engaged in productive discussions with industry partners on key topics, including peptide APIs and formulations, integrated CRO/CMO/CDMO services, process optimization, and quality compliance. Our product quality and technical capabilities received widespread recognition from attendees and partners.
During the expo, Chairman Xu Min attended the Entrepreneurs’ Gala Dinner, where he exchanged insights with industry leaders, experts, and business partners. General Manager Zhang Lan delivered a keynote presentation outlining the company’s core capabilities and strategic roadmap. Technical experts Dr. Yang Zhenya and Ms. Zhang Hong also spoke at specialized breakout sessions, sharing insights into cutting-edge technologies and real-world applications.
At the industry awards ceremony, Suzhou Tianji Biopharma received two major honors:
· Peptide CDMO Excellence in Delivery Award — recognizing the company’s outstanding capabilities in project delivery, project management, and customer service.
· Top 25 Peptide API Companies — recognizing the company as one of China’s leading peptide API manufacturers based on its technical expertise, production capacity, and market performance.
Looking ahead, we will remain committed to our philosophy of “Peptide-Focused, Excellence in Delivery.” We will continue to advance our end-to-end peptide drug development and manufacturing services while creating greater value for partners worldwide.